TheEdgeResearch
Home / Stocks / BCBCF

The BC Bud Corporation (BCBCF)

OTC Healthcare Drug Manufacturers - Specialty & Generic
$0.04 ▼ -3.31%
Market Cap
$6.0M
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Beta
1.98
52-Wk Range
0.003-0.1166
CEO
Brayden Robert Sutton
Country
CA
Currency
USD

The BC Bud Corporation operates in the Drug Manufacturers - Specialty & Generic industry of the Healthcare sector, headquartered in Vancouver, BC, CA. The stock last traded at $0.04, down 3.31% on the session, giving a market capitalisation of $6.0M. On trailing twelve-month figures it carries a trailing P/E of -1.91, a net margin of -1990.9%. Its beta of 1.98 implies it has historically moved more than the broad market.

Valuation & profitability (TTM)
P/E
-1.91
Price / Sales
135.66
Price / Book
384.99
EV / EBITDA
-7.16
Gross margin
96.8%
Operating margin
-1990.0%
Net margin
-1990.9%
Return on equity
Debt / equity
37.83
Current ratio
0.96
Dividend yield
0.0%
Payout ratio
0.0%
Company profile
Exchange
Other OTC
Employees
IPO date
2022-04-29
Headquarters
Vancouver, BC, CA
About The BC Bud Corporation

The BC Bud Corporation is a Canadian entity engaged in the production, commercialization, and licensing of adult-use cannabis products. Their diverse portfolio encompasses traditional dried cannabis flower, a selection of edibles such as chocolate-covered coffee beans sold under the "Canna Beans" brand, and potent concentrates marketed under the "Solventless Solutions" label. Furthermore, they offer cannabis-infused beverages designed to resemble beer, available through their "Buds" brand, and a line of lifestyle-oriented apparel. The company's operations are based in Vancouver, Canada.

Comparable companies

The BC Bud Corporation is most often compared with the following Healthcare names:

ACRDFACRHFCHNCCLSHDOCRFGHSIIVITFNDVAFSQIDFVVCIF
More research on BCBCF
BCBCF technical analysis BCBCF TheEdge Score Compare against peers
Open full interactive analysis & DCF →